GC
Therapeutic Areas
NeuExcell Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NXL-001 | Alzheimer's Disease | Phase 1 |
| NeuroD1 Gene Therapy | Malignant Glioma (GBM) | Phase 1 |
Leadership Team at NeuExcell Therapeutics
MC
Ming Chen, MD
Director, Medical
YC
Yuchen Chen, PhD
Vice President, Board Director
JX
Jie Xu
Co-Founder, Board Director